Melanoma Clinical Trials

Showing 241-260 of 705 trials

Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

NCT05200143

The primary objective of this clinical trial is to evaluate the clinical efficacy and progression free survival of the triplet combination of ipilimumab + nivolumab + cabozantinib in patients with anti-PD-1/PD-L1 refractory metastatic cutaneous melanoma.

Refractory Cutaneous Melanoma

Providence Health & Services4 participantsStarted Jun 2022

Portland, Oregon, United States

ACTIVE_NOT_RECRUITINGPHASE3

Neoadjuvant L19IL2/L19TNF- Pivotal Study

NCT02938299

Phase III, open-label, randomized, controlled multi-center study of the efficacy of L19IL2/L19TNF neoadjuvant intratumoral treatment in Stage III B/C melanoma patients.

Malignant Melanoma

Philogen S.p.A.214 participantsStarted Jul 2016

Marseille, France • Nantes, France • Villejuif, France +19 more locations

Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

Neoadjuvant L19IL2/L19TNF- Pivotal Study

Related Searches

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease

Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

MCS110 With BRAF/MEK Inhibition in Patients With Melanoma

Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors

Nivo/Ipi Combination Therapy in Symptomatic Brain Metastases

A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma

Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma